KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to -$152.6 million.

  • Charles River Laboratories International's Cash from Financing Activities rose 2646.29% to -$152.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$560.7 million, marking a year-over-year decrease of 5953.71%. This contributed to the annual value of -$550.9 million for FY2024, which is 54420.08% down from last year.
  • As of Q3 2025, Charles River Laboratories International's Cash from Financing Activities stood at -$152.6 million, which was up 2646.29% from -$226.9 million recorded in Q2 2025.
  • Charles River Laboratories International's 5-year Cash from Financing Activities high stood at $518.0 million for Q2 2021, and its period low was -$285.9 million during Q2 2024.
  • Over the past 5 years, Charles River Laboratories International's median Cash from Financing Activities value was -$71.5 million (recorded in 2023), while the average stood at -$25.8 million.
  • Per our database at Business Quant, Charles River Laboratories International's Cash from Financing Activities skyrocketed by 59757.44% in 2021 and then tumbled by 67410.33% in 2025.
  • Charles River Laboratories International's Cash from Financing Activities (Quarter) stood at -$219.0 million in 2021, then decreased by 13.69% to -$249.0 million in 2022, then surged by 149.63% to $123.6 million in 2023, then plummeted by 161.41% to -$75.9 million in 2024, then tumbled by 101.13% to -$152.6 million in 2025.
  • Its last three reported values are -$152.6 million in Q3 2025, -$226.9 million for Q2 2025, and -$105.3 million during Q1 2025.